Related Experiment Videos

Mechanism of differences in pathogenicity between two variants of a laboratory strain of herpes simplex virus type 1

Insights

Two herpes simplex virus type 1 (HSV-1) variants showed different neurovirulence in mice. Pre-inoculation with an attenuated HSV-1 variant protected mice from lethal infection by a virulent variant.

Area of Science:

  • Virology
  • Immunology
  • Neuroscience

Background:

  • Herpes simplex virus type 1 (HSV-1) causes a range of human diseases.
  • Understanding HSV-1 neurovirulence mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the mechanisms underlying differential neurovirulence between two HSV-1 variants.
  • To determine the role of initial viral replication and host immune response in HSV-1 neuroinvasion.

Main Methods:

  • Intraperitoneal (i.p.) inoculation of inbred mice with two HSV-1 variants (+GC (LPV) and -GCr).
  • Comparison of viral replication in peritoneal exudate cells (PECs) and central nervous system (CNS) invasion.
  • Assessment of protection conferred by pre-inoculation with the attenuated variant.

Main Results:

  • The virulent +GC (LPV) variant accessed the CNS and caused death, while the attenuated -GCr variant did not.
  • Virulent +GC (LPV) induced significantly higher infective centers (ICs) in PECs than the -GCr variant.
  • Pre-inoculation with the attenuated -GCr variant inhibited virulent +GC (LPV) replication and protected mice from lethal infection.
  • HSV-1 infection resistance in mice was found to be age-dependent.

Conclusions:

  • Differential neurovirulence of HSV-1 variants is linked to their ability to replicate in peritoneal cells and invade the CNS.
  • Attenuated HSV-1 variants can induce protective immunity against virulent strains.
  • Age influences the host's ability to resist HSV-1 infection.

Related Concept Videos